Your request to link to rcsb for hIL-1beta

• 1HIB: the structure of an interleukin-1 beta mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein- protein recognition (10.1021/BI00085A005 )
• 1I1B: crystal structure of recombinant human interleukin-1beta at 2.0 angstroms resolution (10.1016/0022-2836(89)90606-2 )
• 1IOB: interleukin-1 beta from joint x-ray and nmr refinement
• 1ITB: type-1 interleukin-1 receptor complexed with interleukin-1 beta (10.1038/386190A0 )
• 1L2H: crystal structure of interleukin 1-beta f42w/w120f mutant (10.1107/S0907444902021704 )
• 1S0L: interleukin 1 beta mutant f42w (10.1016/J.JMB.2004.11.046 )
• 1T4Q: interleukin 1 beta f101w (10.1016/J.JMB.2004.11.046 )
• 1TOO: interleukin 1b mutant f146w (10.1016/J.JMB.2004.11.046 )
• 1TP0: triple mutation in interleukin 1 beta cavity:replacement of phenylalanines with tryptophan. (10.1016/J.JMB.2004.11.046 )
• 1TWE: interleukin 1 beta mutant f101y (10.1016/J.JMB.2004.11.046 )
• 1TWM: interleukin-1 beta mutant f146y (10.1016/J.JMB.2004.11.046 )
• 21BI: interleukin-1 beta (il-1 beta) (mutant with cys 71 replaced by ala) (c71a)
• 2I1B: crystallographic refinement of interleukin-1 beta at 2.0 angstroms resolution (10.1073/PNAS.86.24.9667 )
• 2KH2: solution structure of a scfv-il-1b complex (10.1074/JBC.M109.025304 )
• 2NVH: determination of solvent content in cavities in interleukin-1 using experimentally-phased electron density (10.1073/PNAS.0609442104 )
• 31BI: interleukin-1 beta (il-1 beta) (mutant with cys 71 replaced by ser) (c71s)
• 3LTQ: structure of interleukin 1b solved by sad using an inserted lanthanide binding tag (10.1021/JA104983T )
• 3O4O: crystal structure of an interleukin-1 receptor complex (10.1038/NI.1925 )
• 3POK: interleukin-1-beta lbt l3 mutant (10.1021/JA104983T )
• 41BI: interleukin-1 beta (il-1 beta) (mutant with cys 8 replaced by ala (c8a)
• 4DEP: structure of the il-1b signaling complex (10.1038/NSMB.2260 )
• 4G6J: crystal structure of human il-1beta in complex with the therapeutic antibody binding fragment of canakinumab (10.1016/J.JMB.2012.09.021 )
• 4G6M: crystal structure of human il-1beta in complex with therapeutic antibody binding fragment of gevokizumab 14-dec-16 4g6m 1 title (10.1016/J.JMB.2012.09.021 )
• 4I1B: functional implications of interleukin-1beta based on the three-dimensional structure (10.1002/PROT.340120103 )
• 5BVP: the molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing il-1beta (10.1080/19420862.2015.1081323 )
• 5I1B: a comparison of the high resolution structures of human and murine interleukin-1b
• 5MVZ: fab 4ab007 bound to interleukin-1-beta
• 5R7W: pandda analysis group deposition of ground-state model of interleukin- 1 beta
• 5R85: pandda analysis group deposition interleukin-1 beta -- fragment z1262246195 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R86: pandda analysis group deposition interleukin-1 beta -- fragment z943693514 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R87: pandda analysis group deposition interleukin-1 beta -- fragment z44592329 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R88: pandda analysis group deposition interleukin-1 beta -- fragment z1545313172 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R89: pandda analysis group deposition interleukin-1 beta -- fragment z217038356 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8A: pandda analysis group deposition interleukin-1 beta -- fragment z1492796719 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8B: pandda analysis group deposition interleukin-1 beta -- fragment z2027049478 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8C: pandda analysis group deposition interleukin-1 beta -- fragment z30857828 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8D: pandda analysis group deposition interleukin-1 beta -- fragment z1745658474 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8E: pandda analysis group deposition interleukin-1 beta -- fragment z57475877 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8F: pandda analysis group deposition interleukin-1 beta -- fragment z2377835233 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8G: pandda analysis group deposition interleukin-1 beta -- fragment z1259086950 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8H: pandda analysis group deposition interleukin-1 beta -- fragment z111716368 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8I: pandda analysis group deposition interleukin-1 beta -- fragment z210803634 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8J: pandda analysis group deposition interleukin-1 beta -- fragment z355728146 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8K: pandda analysis group deposition interleukin-1 beta -- fragment z355728146 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8L: pandda analysis group deposition interleukin-1 beta -- fragment z1891773393 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8M: pandda analysis group deposition interleukin-1 beta -- fragment z1818332938 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8N: pandda analysis group deposition interleukin-1 beta -- fragment z57292400 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8O: pandda analysis group deposition interleukin-1 beta -- fragment z1881545321 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8P: pandda analysis group deposition interleukin-1 beta -- fragment z818727262 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 5R8Q: pandda analysis group deposition interleukin-1 beta -- fragment z2643472210 in complex with interleukin-1 beta (10.1021/ACS.JMEDCHEM.0C00403 )
• 6I1B: high-resolution three-dimensional structure of interleukin- 1 beta in solution by three-and four-dimensional nuclear magnetic resonance spectroscopy (10.1021/BI00223A005 )
• 6Y8I: fragment kcl_i013 in complex with il-1-beta
• 6Y8M: fragment bikinin bound to interleukin 1 beta
• 7CHY: crystal structure of human il-1beta in complex with antibody binding fragment of igg26 (10.1016/J.JMB.2020.166766 )
• 7CHZ: crystal structure of human il-1beta in complex with antibody binding fragment of igg26a (10.1016/J.JMB.2020.166766 )
• 7I1B: high-resolution three-dimensional structure of interleukin- 1 beta in solution by three-and four-dimensional nuclear magnetic resonance spectroscopy (10.1021/BI00223A005 )
• 9ILB: human interleukin-1 beta (10.1073/PNAS.96.1.103 )